168 related articles for article (PubMed ID: 19417146)
21. Treatment of anthracycline extravasation with dexrazoxane.
Langer SW; Sehested M; Jensen PB
Clin Cancer Res; 2000 Sep; 6(9):3680-6. PubMed ID: 10999761
[TBL] [Abstract][Full Text] [Related]
22. Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells.
Belluti S; Basile V; Benatti P; Ferrari E; Marverti G; Imbriano C
Cell Death Dis; 2013 Aug; 4(8):e756. PubMed ID: 23928695
[TBL] [Abstract][Full Text] [Related]
23. Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways.
Yang Z; Liu Y; Shi C; Zhang Y; Lv R; Zhang R; Wang Q; Wang Y
Oncol Rep; 2017 Feb; 37(2):1011-1019. PubMed ID: 28075472
[TBL] [Abstract][Full Text] [Related]
24. Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.
Wiseman LR; Spencer CM
Drugs; 1998 Sep; 56(3):385-403. PubMed ID: 9777314
[TBL] [Abstract][Full Text] [Related]
25. TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer.
Erriquez J; Becco P; Olivero M; Ponzone R; Maggiorotto F; Ferrero A; Scalzo MS; Canuto EM; Sapino A; Verdun di Cantogno L; Bruna P; Aglietta M; Di Renzo MF; Valabrega G
Gynecol Oncol; 2015 Sep; 138(3):627-33. PubMed ID: 26100858
[TBL] [Abstract][Full Text] [Related]
26. A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damage.
Thougaard AV; Langer SW; Hainau B; Grauslund M; Juhl BR; Jensen PB; Sehested M
Toxicology; 2010 Feb; 269(1):67-72. PubMed ID: 20079798
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid esters of phloridzin induce apoptosis of human liver cancer cells through altered gene expression.
Nair SV; Ziaullah ; Rupasinghe HP
PLoS One; 2014; 9(9):e107149. PubMed ID: 25229655
[TBL] [Abstract][Full Text] [Related]
28. Dexrazoxane (ICRF-187).
Weiss G; Loyevsky M; Gordeuk VR
Gen Pharmacol; 1999 Jan; 32(1):155-8. PubMed ID: 9888268
[TBL] [Abstract][Full Text] [Related]
29. TOPBP1 recruits TOP2A to ultra-fine anaphase bridges to aid in their resolution.
Broderick R; Nieminuszczy J; Blackford AN; Winczura A; Niedzwiedz W
Nat Commun; 2015 Mar; 6():6572. PubMed ID: 25762097
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
Boland MP; Fitzgerald KA; O'Neill LA
J Biol Chem; 2000 Aug; 275(33):25231-8. PubMed ID: 10940316
[TBL] [Abstract][Full Text] [Related]
31. Translational control of TOP2A influences doxorubicin efficacy.
Srikantan S; Abdelmohsen K; Lee EK; Tominaga K; Subaran SS; Kuwano Y; Kulshrestha R; Panchakshari R; Kim HH; Yang X; Martindale JL; Marasa BS; Kim MM; Wersto RP; Indig FE; Chowdhury D; Gorospe M
Mol Cell Biol; 2011 Sep; 31(18):3790-801. PubMed ID: 21768308
[TBL] [Abstract][Full Text] [Related]
32. Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.
Bakheet SA; Attia SM; Al-Rasheed NM; Al-Harbi MM; Ashour AE; Korashy HM; Abd-Allah AR; Saquib Q; Al-Khedhairy AA; Musarrat J
Mutagenesis; 2011 Jul; 26(4):533-43. PubMed ID: 21430063
[TBL] [Abstract][Full Text] [Related]
33. Topoisomerase levels determine chemotherapy response in vitro and in vivo.
Burgess DJ; Doles J; Zender L; Xue W; Ma B; McCombie WR; Hannon GJ; Lowe SW; Hemann MT
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9053-8. PubMed ID: 18574145
[TBL] [Abstract][Full Text] [Related]
34. Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
Atwal M; Lishman EL; Austin CA; Cowell IG
Mol Pharmacol; 2017 Jan; 91(1):49-57. PubMed ID: 27974636
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
[TBL] [Abstract][Full Text] [Related]
36. The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent Dexrazoxane.
Hasinoff BB; Patel D; Wu X
Cardiovasc Toxicol; 2020 Jun; 20(3):312-320. PubMed ID: 31773441
[TBL] [Abstract][Full Text] [Related]
37. Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells.
Roti Roti EC; Salih SM
Biol Reprod; 2012 Mar; 86(3):96. PubMed ID: 22190700
[TBL] [Abstract][Full Text] [Related]
38. Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer.
Almeida D; Gerhard R; Leitão D; Davilla C; Damasceno M; Schmitt F
Pathol Res Pract; 2014 Oct; 210(10):675-9. PubMed ID: 25042383
[TBL] [Abstract][Full Text] [Related]
39. Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site.
Hasinoff BB; Creighton AM; Kozlowska H; Thampatty P; Allan WP; Yalowich JC
Mol Pharmacol; 1997 Nov; 52(5):839-45. PubMed ID: 9351975
[TBL] [Abstract][Full Text] [Related]
40. DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac.
Wartlick F; Bopp A; Henninger C; Fritz G
Biochim Biophys Acta; 2013 Dec; 1833(12):3093-3103. PubMed ID: 23999236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]